A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies

Clinical trial NCT03440437 · TERMINATED

Trial details

NCT number: NCT03440437
Sponsor: invoX Pharma Limited
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Squamous Cell Carcinoma of Head and Neck

Start date: 2018-04-16
Primary completion: 2024-06-21
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.